Navigation Links
Circumcision Guards Against STDs
Date:3/25/2009

Study finds procedure dramatically reduces transmission of herpes, human papillomavirus

WEDNESDAY, March 25 (HealthDay News) -- The decision of whether or not to circumcise an infant can be a difficult one, but new research suggests that having the procedure may reduce the risk of certain infections later in life.

In a study of more than 5,000 uncircumcised adult Ugandan males, researchers found that after circumcision, the rates of infection with the virus that causes herpes went down by 28 percent, and the transmission of human papillomavirus (HPV) -- the virus that can cause cervical cancer and genital warts -- was reduced by 35 percent.

In a previous study, the same researchers found that circumcision reduced infection with the HIV virus by 60 percent. Two other research groups -- one working in Kenya and the other in South Africa -- have also had similar findings.

"We hope these data will ultimately result in policy changes in recommending circumcision for young boys or adult men to decrease the rates of infection with HIV, HPV and herpes," said the lead author of the Ugandan study, Dr. Thomas Quinn, a senior investigator in infectious diseases at the National Institute for Allergy and Infectious Diseases (NIAID) and a professor of medicine at Johns Hopkins School of Medicine in Baltimore.

Results of Quinn's study appear in the March 26 issue of the New England Journal of Medicine.

Quinn said there are several reasons that removing the foreskin of the penis might help reduce transmission of certain infections. The foreskin, he explained, has two different sides. The outside is much like regular skin cells. However, the inside is mucosal, similar to a woman's vagina, Quinn explained. During intercourse, the skin side is pulled back and the mucosal side is open and exposed. And, he said, it's likely that there are viral receptors on that mucosal side that make it easier for a virus t
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Clearinghouse on Male Circumcision for HIV Prevention Web Site Launched
2. Circumcision rates lower in states where Medicaid does not cover procedure
3. Circumcision Rates Too Low
4. Male circumcision may decrease risk of HPV infection and cervical cancer
5. Circumcision reduces the risk of HIV infection in heterosexual US men
6. US$18.5 million grant makes male circumcision a top-tier HIV prevention strategy
7. Role of Circumcision in Reducing HIV Risk Still Unclear
8. Study finds circumcision safe in both HIV-infected and HIV-uninfected men
9. Circumcision doesnt reduce sexual satisfaction and performance, says study of 4,500 men
10. Is infant male circumcision an abuse of the rights of the child?
11. NoiseBuster(R) Safeguards Hearing by Utilizing Cutting-Edge Technology to Attenuate Power Equipment Noise
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Circumcision Guards Against STDs
Circumcision Guards Against STDs
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2
...rgery in obese patients, especially in laproscopic...y catheter and an // arterial line, says a study ... Morbid obesity is a condition that has a ge...ts in controlling the obesity. One of the mo...
...placing lost sensory hair cells in the inner ear m...mals, say a recent study// published in Nature Med... viral vector found in a developmental regulatory ...row as the differentiated non-sensory cells of the...
...e researchers at Harvard School of Public Health h...duce the risk of having multiple// sclerosis (MS) ...amin D supplement had a 40% less chance of develop...here is no cure for this disease but modern day tr...
... is possible to reduce eye infections like keratit... for longer hours, reports British Journal// of Op...e on contact lens wearers for daily wear or extend...earers for a 12-month hospital based study and had...
...alysis of medical records of liver cancer patients...ics are stand a three fold risk // of developing l... After taking other factors into account, such as ...hich is a known risk factor for liver cancer, may ...
... the 83rd General Session of the International Ass..., Japanese scientists have presented the results o...good for people suffering from bad breath. Or...had sugar-free more and natural form of yogurt for...
Other Medicine News:
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6William Dwyer Named to PerfectServe Advisory Board 57496 1William Dwyer Named to PerfectServe Advisory Board 57496 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 1Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 3Cyberonics to Present at Maxim Group Growth Conference 57492 1Cyberonics to Present at Maxim Group Growth Conference 57492 2
... Reported Safety & Tolerability Profile,in Sub...CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase I...of the American Diabetes,Association demonstrated ...dase-4 (DPP-4) in development by Bristol-Myers,Squ...), in,combination with metformin, exhibited a stat...
...-Funded Immune Globulin Study Uncovers Sample,Mani...PRNewswire-USNewswire/ -- An analysis,released tod...,study ruling out a link between autism and Rh imm...ained the mercury-based,preservative thimerosal. B...red manipulation of the study sample, so that,earl...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3
QuikCoag CaCl2
QuikCoag Control 2
..., compact design. Using optical light scatter for ...YN 3200 meets the needs of today's laboratory. The...-part differential analysis, automated sample hand...y. The system combines proven Multi-Angle Polarize...
Perclose A-T Suture-Mediated Closure
Medicine Products: